{"id":"W2028748733","doi":"10.1016/j.nicl.2013.07.006","title":"Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging","year":2013,"lang":"en","type":"article","venue":"NeuroImage Clinical","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"University of California, San Diego; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; University of California, Los Angeles; GE Healthcare; Genentech; National Institutes of Health; U.S. National Library of Medicine; Takeda Pharmaceutical Company; IXICO; Servier; Eisai; Northern California Institute for Research and Education; Synarc; Bayer HealthCare; Meso Scale Diagnostics; Medpace; DoD Alzheimer's Disease Neuroimaging Initiative; BioClinica; Pfizer; Biogen; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Novartis Pharmaceuticals Corporation; Alzheimer's Association; Amorfix Life Sciences; Alzheimer's Drug Discovery Foundation; Merck; National Institute on Aging; Abbott Laboratories; National Center for Research Resources; F. Hoffmann-La Roche","keywords":"Fractional anisotropy; Diffusion MRI; White matter; Psychology; Neuroimaging; Cingulum (brain); Alzheimer's Disease Neuroimaging Initiative; Dementia; Alzheimer's disease; Neuroscience; Medicine; Nuclear medicine; Cognitive impairment; Magnetic resonance imaging; Cognition; Disease; Internal medicine; Radiology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1785441551005502,"score_gpt":0.4330612784330466,"score_spread":0.2545171233324964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}